Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer
Saved in:
| Published in: | Journal of Experimental Pharmacology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301673286762498 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Journal of Experimental Pharmacology |
| description | |
| discipline_display | Laboratory and Experimental Medicine |
| discipline_facet | Laboratory and Experimental Medicine |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:67013 |
| institution | FRELIP |
| journal_source_facet | Journal of Experimental Pharmacology |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| subject_facet | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| title | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_auth | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_full | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_fullStr | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_full_unstemmed | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_short | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_sort | in vivo therapeutic inhibition of the tp53-induced glycolysis and apoptosis regulator (tigar) by intravenous administration of an anti-oncological sirna-biopolymer, ti6752 (tituxistatin), in a preclinical xenograft model of colorectal cancer |
| topic | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| url | https://www.dovepress.com/in-vivo-therapeutic-inhibition-of-the-tp53-induced-glycolysis-and-apop-peer-reviewed-fulltext-article-JEP |